Search research articles
Contact Us
Filters
Showing results (281-290 of 319) with videos related to
Page
of 32
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
April 5, 2011
Comparative biodistribution of 12 ¹¹¹In-labelled gastrin/CCK2 receptor-targeting peptides
Peter Laverman, Lieke Joosten, Annemarie Eek, et al.
European Urology
|
September 18, 2012
Phase 1 radioimmunotherapy study with lutetium 177-labeled anti-carbonic anhydrase IX monoclonal antibody girentuximab in patients with advanced renal cell carcinoma
Alexander B Stillebroer, Otto C Boerman, Ingrid M E Desar, et al.
Molecular Pharmaceutics
|
October 9, 2014
Cetuximab reduces the accumulation of radiolabeled bevacizumab in cancer xenografts without decreasing VEGF expression
Sandra Heskamp, Otto C Boerman, Janneke D M Molkenboer-Kuenen, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
September 25, 2003
Long-lived positron emitters zirconium-89 and iodine-124 for scouting of therapeutic radioimmunoconjugates with PET
Iris Verel, Gerard W M Visser, Otto C Boerman, et al.
Theranostics
|
May 11, 2016
Towards Personalized Treatment of Prostate Cancer: PSMA I&T, a Promising Prostate-Specific Membrane Antigen-Targeted Theranostic Agent
Kristell L S Chatalic, Sandra Heskamp, Mark Konijnenberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 22, 2014
Preclinical comparison of Al18F- and 68Ga-labeled gastrin-releasing peptide receptor antagonists for PET imaging of prostate cancer
Kristell L S Chatalic, Gerben M Franssen, Wytske M van Weerden, et al.
EJNMMI Physics
|
October 27, 2015
Tumor and red bone marrow dosimetry: comparison of methods for prospective treatment planning in pretargeted radioimmunotherapy
Wietske Woliner-van der Weg, Rafke Schoffelen, Robert F Hobbs, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 20, 2014
Predictive patient-specific dosimetry and individualized dosing of pretargeted radioimmunotherapy in patients with advanced colorectal cancer
Rafke Schoffelen, Wietske Woliner-van der Weg, Eric P Visser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 6, 2005
Radioimmunotherapy with [131I]cG250 in patients with metastasized renal cell cancer: dosimetric analysis and immunologic response
Adrienne H Brouwers, Wilhelmina C A M Buijs, Peter F A Mulders, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 6, 2016
In Vivo Imaging of Antileukemic Drug Asparaginase Reveals a Rapid Macrophage-Mediated Clearance from the Bone Marrow
Laurens T van der Meer, Samantha Y A Terry, Dorette S van Ingen Schenau, et al.
Page
of 32
Search research articles
Search
Showing results (281-290 of 319) with videos related to
Sort By:
Page
of 32
European Journal of Nuclear Medicine and Molecular Imaging
|
April 5, 2011
Comparative biodistribution of 12 ¹¹¹In-labelled gastrin/CCK2 receptor-targeting peptides
Peter Laverman, Lieke Joosten, Annemarie Eek, et al.
European Urology
|
September 18, 2012
Phase 1 radioimmunotherapy study with lutetium 177-labeled anti-carbonic anhydrase IX monoclonal antibody girentuximab in patients with advanced renal cell carcinoma
Alexander B Stillebroer, Otto C Boerman, Ingrid M E Desar, et al.
Molecular Pharmaceutics
|
October 9, 2014
Cetuximab reduces the accumulation of radiolabeled bevacizumab in cancer xenografts without decreasing VEGF expression
Sandra Heskamp, Otto C Boerman, Janneke D M Molkenboer-Kuenen, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
September 25, 2003
Long-lived positron emitters zirconium-89 and iodine-124 for scouting of therapeutic radioimmunoconjugates with PET
Iris Verel, Gerard W M Visser, Otto C Boerman, et al.
Theranostics
|
May 11, 2016
Towards Personalized Treatment of Prostate Cancer: PSMA I&T, a Promising Prostate-Specific Membrane Antigen-Targeted Theranostic Agent
Kristell L S Chatalic, Sandra Heskamp, Mark Konijnenberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 22, 2014
Preclinical comparison of Al18F- and 68Ga-labeled gastrin-releasing peptide receptor antagonists for PET imaging of prostate cancer
Kristell L S Chatalic, Gerben M Franssen, Wytske M van Weerden, et al.
EJNMMI Physics
|
October 27, 2015
Tumor and red bone marrow dosimetry: comparison of methods for prospective treatment planning in pretargeted radioimmunotherapy
Wietske Woliner-van der Weg, Rafke Schoffelen, Robert F Hobbs, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 20, 2014
Predictive patient-specific dosimetry and individualized dosing of pretargeted radioimmunotherapy in patients with advanced colorectal cancer
Rafke Schoffelen, Wietske Woliner-van der Weg, Eric P Visser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 6, 2005
Radioimmunotherapy with [131I]cG250 in patients with metastasized renal cell cancer: dosimetric analysis and immunologic response
Adrienne H Brouwers, Wilhelmina C A M Buijs, Peter F A Mulders, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 6, 2016
In Vivo Imaging of Antileukemic Drug Asparaginase Reveals a Rapid Macrophage-Mediated Clearance from the Bone Marrow
Laurens T van der Meer, Samantha Y A Terry, Dorette S van Ingen Schenau, et al.
Page
of 32